(ABM FN) The Brussels stock market continued to fall on Friday afternoon. Just after two hours, the Bel20 fell 1.4 percent to 4,159.24 points.
In the main index, only Telenet manages to keep its head above water, with a gain of 1.1 percent. At the bottom of the Bel20 are Aperam and Umicore with declines of 3.5 and 3.0 percent.
Kepler Cheuvreux has slightly changed the price target for Ageas from EUR 42.50 to EUR 42.90, with a recommendation to Reduce. The broker expects the insurer to narrowly meet its net profit forecast for 2021. But it still comes to 3.4 percent.
KBC Securities raised Sofina’s price target to EUR 390.00 with a Hold recommendation. Degroof Petercam has also revised the price target to 372.00 euros and the advice of Reduce to Hold. Holding annual sales of 11 euros, of 330 euros per share, from 330 euros per share, which is a turnover of almost 7 percent at the beginning of 2021. The stock is losing 0.8 percent.
UCB has again achieved positive results with bimekizumab, this time in a Phase 3 BE COMPLETE study for the treatment of psoriatic arthritis. The pharmaceutical company expects to submit marketing applications for the treatment in the third quarter. It is useful to hold the winnings and gain 0.1 percent.
In the BelMid, there is an increase of 1.2 percent, while Ontex is emerging with 4.4 percent.
Kepler Cheuvreux raised the price target for Kinepolis from 62.00 to 71.00 euros with a colorful buy recommendation. The stock is down 1.8 percent.
Degroof Petercam has changed the price target for Retail Estates from 74.00 to 80.00 euros with an unchanged buy recommendation. The share had to lose 1.1 percent.
Agfa-Gevaert increased its prices for PCB phototooling and medical products. The price increases are the result of high transport costs and high raw material prices, which, according to Degroof Petercam, are difficult to achieve. According to the stock exchange, these increases show that the situation is very difficult for Agfa, but the company is taking the right measures. It costs 0.8 percent.
Econocom has Laurent Roudil as general manager and CEO and Angel as general manager. According to Kepler Cheuvreux, this will not change the company’s strategy much, while Degroof Petercam believes it is a clear improvement of the management of Econocom. The stock lost 3.0 percent.
Texaf gains 2.2 percent of the smaller shares and Acacia Pharma leaves 3.0 percent.
Source: ABM Financial News
From Beursplein 5, the editors of Financial news from ABM keep a close eye on developments on the stock exchanges, and the Amsterdam stock exchange in particular. The information in this column is not intended as professional investment advice or as a recommendation to make.